Cutting-edge eVTOL for your own personal use Custom livery and all essentials included, like premium flight deck and 4K ...
Cassava Sciences' stock fell after Phase 3 simufilam trial failed to meet key endpoints, prompting the discontinuation of its Alzheimer's studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback